C. Natoli et al., ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV), Anticancer research, 14(3B), 1994, pp. 1457-1460
Levels of a 90,000 daltons monoclonal antibody-defined tumor-associate
d antigen, termed 90K, were measured in the serum from 649 patients wi
th various types of cancer and 1215 patients infected by the human imm
unodeficiency virus (HIV). Significantly increased 90K serum levels (1
2.1+/-0.5 U/ml) were found in cancer patients with respect to healthy
controls (5.7+/-0.3 U/ml), with the highest levels in neoplasms of the
breast, lung and gastrointestinal tract. In 355 patients with breast
cancer, the elevation of serum 90K levels was more pronounced at advan
ced stages of disease. Mean levels of 90K for 1215 HIV-infected subjec
ts (21.2+/-0.8 U/ml) were significantly higher than controls and cance
r patients, and the levels progressively increased with disease worsen
ing from asymptomatic infection to full blown AIDS. These data suggest
that 90K is not merely a tumor-associated antigen and lead us to post
ulate it to be a signalling molecule whose production might be related
to the immune deficit caused by pathogenetic events such as neoplasti
c progression and virus infection.